Library / regulatory-reference
Jordan: Jordan Food and Drug Administration (JFDA)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Jordan Food and Drug Administration, known by its initials JFDA, is Jordan's national regulator for food and medicines, established in 2003 under the national food and drug law and operating under the Ministry of Health.
Jordan punches above its size in pharmaceuticals: a well-developed domestic manufacturing sector exports across the Middle East and North Africa, so the authority's registration and inspection work matters beyond the domestic market.
How products enter the market
Medicines require registration after evaluation of quality, safety and efficacy, and the authority licenses manufacturers, importers, pharmacies and distributors. Domestic plants and foreign suppliers are subject to good-manufacturing-practice requirements and inspection.
Post-market work includes market surveillance, product testing through the authority's laboratories, and pharmacovigilance reporting collected from health professionals and companies.
Regional and international role
The authority participates in Arab and international regulatory cooperation, and Jordan's export-oriented industry keeps its inspection and certification outputs, such as certificates of pharmaceutical product, in routine use across the region.
Regulatory development in Jordan is often cited as a model for mid-income countries building medicines oversight with limited resources.
Using this profile
The authority publishes guidance, circulars and product-status information in Arabic and English through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the JFDA illustrates the export-economy regulator: a mid-sized authority whose certification and inspection outputs support an industry selling well beyond the national market.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.